111 related articles for article (PubMed ID: 26700459)
21. Intronic DNA elements regulate Nrf2 chemical responsiveness of the human microsomal epoxide hydrolase gene (EPHX1) through a far upstream alternative promoter.
Su S; Yang X; Omiecinski CJ
Biochim Biophys Acta; 2014 Jun; 1839(6):493-505. PubMed ID: 24704207
[TBL] [Abstract][Full Text] [Related]
22. Acetyl-l-carnitine prevents homocysteine-induced suppression of Nrf2/Keap1 mediated antioxidation in human lens epithelial cells.
Yang SP; Yang XZ; Cao GP
Mol Med Rep; 2015 Jul; 12(1):1145-50. PubMed ID: 25776802
[TBL] [Abstract][Full Text] [Related]
23. Nrf2 silencing to inhibit proteolytic defense induced by hyperthermia in HT22 cells.
Bozaykut P; Ozer NK; Karademir B
Redox Biol; 2016 Aug; 8():323-32. PubMed ID: 26966891
[TBL] [Abstract][Full Text] [Related]
24. Nrf2-heme oxygenase-1 axis in mucoepidermoid carcinoma of the lung: Antitumoral effects associated with down-regulation of matrix metalloproteinases.
Tertil M; Golda S; Skrzypek K; Florczyk U; Weglarczyk K; Kotlinowski J; Maleszewska M; Czauderna S; Pichon C; Kieda C; Jozkowicz A; Dulak J
Free Radic Biol Med; 2015 Dec; 89():147-57. PubMed ID: 26393425
[TBL] [Abstract][Full Text] [Related]
25. Transcriptional regulation of activating transcription factor 4 under oxidative stress in retinal pigment epithelial ARPE-19/HPV-16 cells.
Miyamoto N; Izumi H; Miyamoto R; Bin H; Kondo H; Tawara A; Sasaguri Y; Kohno K
Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1226-34. PubMed ID: 21087962
[TBL] [Abstract][Full Text] [Related]
26. FGF9-induced changes in cellular redox status and HO-1 upregulation are FGFR-dependent and proceed through both ERK and AKT to induce CREB and Nrf2 activation.
Chuang JI; Huang JY; Tsai SJ; Sun HS; Yang SH; Chuang PC; Huang BM; Ching CH
Free Radic Biol Med; 2015 Dec; 89():274-86. PubMed ID: 26424114
[TBL] [Abstract][Full Text] [Related]
27. Lysophosphatidate signaling stabilizes Nrf2 and increases the expression of genes involved in drug resistance and oxidative stress responses: implications for cancer treatment.
Venkatraman G; Benesch MG; Tang X; Dewald J; McMullen TP; Brindley DN
FASEB J; 2015 Mar; 29(3):772-85. PubMed ID: 25398768
[TBL] [Abstract][Full Text] [Related]
28. Invasion potential of H22 hepatocarcinoma cells is increased by HMGB1-induced tumor NF-κB signaling via initiation of HSP70.
Gong W; Wang ZY; Chen GX; Liu YQ; Gu XY; Liu WW
Oncol Rep; 2013 Sep; 30(3):1249-56. PubMed ID: 23836405
[TBL] [Abstract][Full Text] [Related]
29. Nrf2 knockdown by shRNA inhibits tumor growth and increases efficacy of chemotherapy in cervical cancer.
Ma X; Zhang J; Liu S; Huang Y; Chen B; Wang D
Cancer Chemother Pharmacol; 2012 Feb; 69(2):485-94. PubMed ID: 21842204
[TBL] [Abstract][Full Text] [Related]
30. Proteasome inhibitor MG132 induces BAG3 expression through activation of heat shock factor 1.
Du ZX; Zhang HY; Meng X; Gao YY; Zou RL; Liu BQ; Guan Y; Wang HQ
J Cell Physiol; 2009 Mar; 218(3):631-7. PubMed ID: 19006120
[TBL] [Abstract][Full Text] [Related]
31. Histone deacetylase inhibitors induce thyroid cancer-specific apoptosis through proteasome-dependent inhibition of TRAIL degradation.
Borbone E; Berlingieri MT; De Bellis F; Nebbioso A; Chiappetta G; Mai A; Altucci L; Fusco A
Oncogene; 2010 Jan; 29(1):105-16. PubMed ID: 19802013
[TBL] [Abstract][Full Text] [Related]
32. [The role of NF-E2-related factor 2 in the induction of uridine 5'-diphosphate-glucuronosyltransferase 1A and its isoforms by epigallocatechin gallate in colon cancer cells].
Yang XY; Zhao WP; Li YQ; Sun ZY; Zhang Y; Guo YT; Yuan JH; Zhu Q; Wang M
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):82-7. PubMed ID: 16620709
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activity.
Arlt A; Sebens S; Krebs S; Geismann C; Grossmann M; Kruse ML; Schreiber S; Schäfer H
Oncogene; 2013 Oct; 32(40):4825-35. PubMed ID: 23108405
[TBL] [Abstract][Full Text] [Related]
34. Protection of vascular cells from oxidative stress by proteasome inhibition depends on Nrf2.
Dreger H; Westphal K; Wilck N; Baumann G; Stangl V; Stangl K; Meiners S
Cardiovasc Res; 2010 Jan; 85(2):395-403. PubMed ID: 19679681
[TBL] [Abstract][Full Text] [Related]
35. Beclin 1 enhances proteasome inhibition-mediated cytotoxicity of thyroid cancer cells in macroautophagy-independent manner.
Zhang HY; Du ZX; Meng X; Zong ZH; Wang HQ
J Clin Endocrinol Metab; 2013 Feb; 98(2):E217-26. PubMed ID: 23264393
[TBL] [Abstract][Full Text] [Related]
36. Histone deacetylase inhibitor depsipeptide represses nicotinamide N-methyltransferase and hepatocyte nuclear factor-1beta gene expression in human papillary thyroid cancer cells.
Xu J; Hershman JM
Thyroid; 2006 Feb; 16(2):151-60. PubMed ID: 16676400
[TBL] [Abstract][Full Text] [Related]
37. Transcription factor Nrf2: examination of nuclear protein levels by immunoblotting and promoter response element binding by chromatin immunoprecipitation (ChIP).
Shay KP; Smith EJ; Hagen TM
Curr Protoc Toxicol; 2010 Aug; Chapter 17():Unit17.13. PubMed ID: 23045018
[TBL] [Abstract][Full Text] [Related]
38. 15-Deoxy-delta 12, 14-prostaglandin J2 induces upregulation of multidrug resistance-associated protein 1 via Nrf2 activation in human breast cancer cells.
Song NY; Kim DH; Kim EH; Na HK; Surh YJ
Ann N Y Acad Sci; 2009 Aug; 1171():210-6. PubMed ID: 19723058
[TBL] [Abstract][Full Text] [Related]
39. Regulation of hemeoxygenase-1 gene expression by Nrf2 and c-Jun in tertiary butylhydroquinone-stimulated rat primary astrocytes.
Park JS; Kim HS
Biochem Biophys Res Commun; 2014 May; 447(4):672-7. PubMed ID: 24755082
[TBL] [Abstract][Full Text] [Related]
40. The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.
Chen YL; Uen YH; Li CF; Horng KC; Chen LR; Wu WR; Tseng HY; Huang HY; Wu LC; Shiue YL
Ann Surg Oncol; 2013 Nov; 20(12):4041-54. PubMed ID: 22911364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
